Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

Tread Carefully, But Sorrento Stock Could Continue to Bounce Back

So, what's the call here? If you have a high risk tolerance, and are looking for a short-term pandemic play, SRNE stock today may be worth the risk. Just don't bet the ranch.

Flights of Necessity Don’t Do Much for Delta Air Lines

For the warm and fuzzies, DAL stock wins out due to Delta Air Lines commitment to in-flight social distancing. But the harsh reality is that passengers just aren’t flying like they used to.

Novavax Investors Betting They Have the COVID-19 Solution

Novavax has gotten $2 billion in support from the government, and is rushing its COVID-19 vaccine candidate through trials, hoping its adjuvant makes for fast distribution.

Kensington Capital Could Be a Breakout Star in the Electric Car Space

Not everyone's heard of Kensington Capital stock yet, but traders will be forced to pay attention as this isn't your ordinary shell company.

Improving Sales Trajectory Makes Nio Even More Attractive

Vehicle deliveries are the lifeblood of automakers, and Nio stock's ascent should continue as long as the company's sales figures stay up.

Workhorse Group Shares Are Overvalued, But Catalysts May Lift Its Stock Further

Short-term traders with gains in WKHS stock may want to take money off the table

For Better or Worse, Plug Power Isn’t the Next Tesla

Both bulls and bears like to compare PLUG stock to Tesla. However, Plug Power's own business struggles are more concerning.

Why Plug Power May Fizzle With Lower Oil Prices

PLUG stock is one of the hottest stocks of 2020, but the low natural gas prices that make hydrogen energy attractive may be coming to an end.

Snowflake Needs to Come Back to Earth Before It’s a Buy

SNOW stock is a long-term winner, but investors can afford to wait for better prices before buying the freshly public stock.

Oracle Stock Rallies Monday on Approval of TikTok Deal

Oracle stock is rallying Monday on news President Donald Trump has approved its bid for TikTok. Here's why that matters now.

4 Hydrogen Stocks to Watch for the Future

Hydrogen stocks can offer exposure to the growing economy for clean energy. Here are four to keep an eye on, even if they're expensive here.

If Apple Creates a Watch Supercycle, AAPL Stock Can Run

Blood oxygen detection and exciting 5G capabilities could launch an Apple Watch supercycle, boosting AAPL stock.

Nvidia’s $40 Billion Deal Brings a Stock Split into the Picture

Nvidia’s paying $40 billion for U.K.-based ARM Holdings. That’s pushed NVDA stock past $500. Is it time for the company to split its stock?

Landcadia Stock Looks Great on Paper, but Take a Look at the Fine Print First

If you trust in Tilman Fertitta and don't mind the related party transactions, LCA stock could be a sizzling play on the growth of online gaming.

Weighing Chewy’s Pros and Cons After a Volatile Year

Chewy's secondary offering may give patient investors a dip-buying opportunity in CHWY stock. But be mindful of these risks before you jump in.

How Far Can Delta Stock Rally As It Begins to Break Higher?

Delta stock is finally catching some upside momentum, as are its peers. Can DAL stock continue to fly or will it be grounded soon? Let's look.

How to Play the #CancelNetflix Dip

NFLX stock is down 11% since the #CancelNetflix social media campaign gained steam. But most subscribers that leave Netflix will be back.

GM Makes Nikola Stock Interesting Despite the Heat

Due to a devastating short seller’s report, Nikola stock has many question marks. Still, that may not be enough to completely overturn the speculative argument.

Vaccine Wanna-be iBio Stock Remains a Gamble Even After New Partnership

A recent deal on developing a Covid-19 therapy is getting attention but IBIO stock is still a very speculative play in the biopharma space.